People on the Move
Jeffrey A. Chodakewitz
Vertex Pharmaceuticals Inc has appointed Jeffrey A. Chodakewitz to Chief Medical Officer and senior VP.
Before Vertex, Chodakewitz led many research projects at Merck & Co., including overseeing the development of the Gardasil vaccine against cervical cancer and Crixivan for HIV infection.
Vertex CEO Jeffrey Leiden welcomed Chodakewitz’s previous experience in clinical development.
"Jeff brings deep and broad experience in leading successful development efforts for medicines across multiple diseases. His experience will be invaluable to our current research and development efforts in cystic fibrosis and other serious diseases," said Leiden.
The business’s present Chief Medical Officer, Robert Kauffman, will retire from the company late this year.
